Grants and Contributions:
Title:
Optimizing AI portability and scalability for personalized therapeutic music intervention in dementia care
Agreement Number:
1033045
Agreement Value:
$300,000.00
Agreement Date:
Jul 2, 2025 - Jul 15, 2026
Description:
This project aims to enhance LUCID’s AI-driven music therapeutic system for dementia care by integrating and developing scalable and portable AI modules. These advancements will enable personalized music interventions to scale to a larger population in the United States and in the Pacific region, with an initial focus on Japan and South Korea.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5C 1K9
Reference Number:
172-2025-2026-Q2-1033045
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
784783318
Recipient Type:
For-profit organization
Recipient's Operating Name:
Lucid Therapeutics
Recipient's Legal Name:
Lucid, inc.
Federal Riding Name:
Toronto Centre
Federal Riding Number:
35108
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
51121